Oklahoma Life Science Fund
VC Fund
Tulsa, United States
Oklahoma Life Science Fund is a VC fund in Tulsa focused on Health Care and Medical. OLSF I is invested in five start-ups that have created over 100 jobs with a mean income that is three times greater than the state average. These companies have attracted over $210 million in venture capital from regional and national venture capital firms after OLSF's first investment.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 38%
Last updated:
For AI agents: llms.txt
Industries Oklahoma Life Science Fund invests in
Stages Oklahoma Life Science Fund invests in
Countries Oklahoma Life Science Fund invests in
Investment Focus
Industry
- Health Care 3 (38%)
- Medical 2 (25%)
- Mobile 1 (13%)
- Software 1 (13%)
- Fertility 1 (13%)
Stage
- Series A 4 (50%)
- Seed 2 (25%)
- Series B 1 (13%)
- Funding Round 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cadenza Bio
|
Cadenza Bio accelerates and supports the development of a new class of highly selective Estrogen Receptor targeted small molecules. We are committed to developing therapeutic medications that will improve the lives of patients suffering from terrible diseases. | $2.4M / Seed / Dec 14, 2023 | |
Mate Fertility
|
think fertility treatment is complicated? (so did we!)we’re a group of fertility doctors making the path to parenthood less complicated, less expensive, and a lot more accessible. and we’re doing it with an always-available network of fertility centers run by experts who care, a branded experience that brings all resources under one roof,state-of-the-art treatments clearly explained and easily kept track of, and services delivered in a positive, warm environment. we're creating a simpler way to go from "i want a baby" to "i'm a parent." fertility for all starts here.Founded by the blended family team of brothers Oliver Bogner and Gabriel Bogner, Reproductive Endocrinologist Dr. Jeffrey Steinberg, and Lauren Steinberg (also founder of Queen V). The mate brand was created in partnership with Partners & Spade (Hims/Hers, Warby Parker, Harrys/Flamingo), and clinics designed by Heitler Houstoun Architects (Dry Bar, Henry The Dentist, Madison Reed). | $5.2M / Series A / Mar 28, 2023 | |
Access Optics
|
Access Optics is able to combine innovating manufacturing engineering, process development, and optical fabrication with advanced coating technology. The pioneering product development and advanced materials solutions have fostered breakthrough products for leading OEMs in endoscopy, dermatology, aerospace, and chromatography. | $4.5M / Series A / Oct 25, 2021 | |
Recuro Health
|
Recuro Health delivers value throughout the healthcare ecosystem with an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease focused model to a population health, outcomes approach. | $15M / Series A / Aug 25, 2021 | |
|
Recuro Health
|
Recuro Health delivers value throughout the healthcare ecosystem with an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease focused model to a population health, outcomes approach. | Mar 30, 2021 | |
|
Recuro Health
|
Recuro Health delivers value throughout the healthcare ecosystem with an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease focused model to a population health, outcomes approach. | Seed / Mar 30, 2021 | |
AliveCor
|
AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. AliveCor is pioneering the creation of FDA-cleared 'machine learning' techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. It specializes in the fields ofhealthcare, mobile device, and medicine.It was founded in 2010 and headquartered in Mountain View, California. | $10.5M / Series B / Jun 10, 2012 | |
|
AliveCor
|
AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. AliveCor is pioneering the creation of FDA-cleared 'machine learning' techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. It specializes in the fields ofhealthcare, mobile device, and medicine.It was founded in 2010 and headquartered in Mountain View, California. | $3M / Series A / Aug 02, 2011 |
Co-Investors
Cortado Ventures
6 deals together
1843 Capital
3 deals together
Sage Venture Partners
3 deals together
Burrill & Company
2 deals together
Plains Ventures
2 deals together
Qualcomm Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Oklahoma Life Science Fund invest in?
Oklahoma Life Science Fund invests primarily in Health Care, Medical and Mobile startups, most often at Series A and Seed stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Oklahoma Life Science Fund last invest?
The most recent investment recorded for Oklahoma Life Science Fund closed in Dec 2023. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
